| Literature DB >> 24739757 |
Ivan Martin1, Paul J Simmons, David F Williams.
Abstract
Along with scientific and regulatory issues, the translation of cell and tissue therapies in the routine clinical practice needs to address standardization and cost-effectiveness through the definition of suitable manufacturing paradigms.Mesh:
Year: 2014 PMID: 24739757 DOI: 10.1126/scitranslmed.3008558
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956